(NYSE: ANVS) Annovis Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 22.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.
Annovis Bio's earnings in 2025 is -$29,060,497.On average, 1 Wall Street analyst forecast ANVS's earnings for 2025 to be -$29,619,071, with the lowest ANVS earnings forecast at -$29,619,071, and the highest ANVS earnings forecast at -$29,619,071.
In 2026, ANVS is forecast to generate -$32,347,143 in earnings, with the lowest earnings forecast at -$32,347,143 and the highest earnings forecast at -$32,347,143.